產(chǎn)品中心
華雅旗下紅榮微再授權(quán)代理(上海)TAKARA CellArtis,Rubicon產(chǎn)品
1500 1904 520 紅榮微再-客服: 經(jīng)銷商專員
產(chǎn)品圖片僅供參考。實際產(chǎn)品包括細胞株+培養(yǎng)基+添加劑+包被劑
人iPS誘導多能干細胞
(Human Induced Pluripotent Stem Cells)
產(chǎn)品英文名稱:Cellartis® Human iPS Cell Lines
產(chǎn)品中文名稱:Cellartis® 人iPS誘導多能干細胞
Cellartis人iPS細胞(Human iPS Cell Line)產(chǎn)品是達到了工業(yè)客戶使用標準生產(chǎn)的干細胞產(chǎn)品。該產(chǎn)品包括細胞和用于增殖培養(yǎng)的Cellartis DEF-CS Culture System培養(yǎng)體系。iPS細胞已經(jīng)在制品化時完成了對DEF-CS培養(yǎng)體系的適應(yīng)。Cellartis DEF-CS Culture System培養(yǎng)體系是組分明確而且不依賴飼養(yǎng)層的便捷的干細胞培養(yǎng)體系。Cellartis DEF-CS Culture System適合高效率地增殖培養(yǎng)干細胞,并且保持干細胞在增殖過程中幾乎無分化地生長,這使得不需要在大規(guī)模增殖培養(yǎng)過程中進行細胞篩選。因此,Cellartis人iPS細胞(Human iPS Cell Line)產(chǎn)品是一套完整的產(chǎn)品體系,對于科研級別和工業(yè)規(guī)模的需求都適合。
Cellartis人iPS誘導多能干細胞特點
☆細胞系通過使用缺陷型多順反子逆轉(zhuǎn)錄病毒(defective polycistronic retrovirus)技術(shù)重編程人皮膚成纖維細胞以轉(zhuǎn)入Oct-4,SOX2,KLF4和c-Myc
☆細胞系的純度和干細胞特征經(jīng)過廣泛分析,包括解凍后的恢復(fù),支原體和細菌檢測,干細胞特異性標記物的表達(Oct-4,NANOG,SSEA-3,SSEA-4,TRA-1 -60,TRA-1-81),不表達分化標記(β-3微管蛋白,F(xiàn)OXA2,ASMA)和預(yù)期核型
☆用Cellartis DEF-CS培養(yǎng)系統(tǒng)優(yōu)化培養(yǎng),試劑盒包括Cellartis DEF-CS 100培養(yǎng)系統(tǒng)
☆適用于所有主要應(yīng)用; 細胞在分化時可以分化形成所有三個胚層的衍生物
Cell lines were created by reprogramming human skin fibroblasts using defective polycistronic retrovirus technology to deliver Oct-4, SOX2, KLF4, and c-Myc
Cell lines are extensively analyzed for purity and stem-cell characteristics, including recovery after thawing, absence of mycoplasma and bacteria, expression of stem cell-specific markers (Oct-4, NANOG, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81), absence of differentiation markers (Beta-3 tubulin, FOXA2, ASMA), and expected Karyotype
Optimized for culture with the Cellartis DEF-CS Culture System
Suitable for all major applications; cells can form derivatives of all three germ layers when differentiated
Kits include the Cellartis DEF-CS 100 Culture System
Cellartis 人iPS誘導多能干細胞參數(shù)
不同貨號對應(yīng)供體年齡性別冷凍代數(shù)和已確認分化能力
1500 1904 520。紅榮微再-客服: 經(jīng)銷商專員
iPS誘導多能干細胞的應(yīng)用
細胞治療、藥物監(jiān)測和疾病模型
Cellartis 人iPS誘導多能干細胞組份
不同供體的iPS細胞系和DEF-CS 100*培養(yǎng)基
*培養(yǎng)基包含基礎(chǔ)培養(yǎng)基、添加劑和包被劑。
保存:細胞 ≤ –150°C,添加劑 –20°C,基礎(chǔ)培養(yǎng)基和包被劑4 °C。
A. Cellartis Human iPS Cell Lines
Cellartis human iPS cell line P11025 (Cat. No. Y00180, not sold separay; sold as a part of Cat.No. Y00185)
Cellartis human iPS cell line P11032 (Cat. No. Y00220, not sold separay; sold as a part of Cat.No. Y00225)
Cellartis human iPS cell line 4 (ChiPSC4) (Cat. No. Y00260, not sold separay; sold as a part of Cat. No. Y00265)
Cellartis human iPS cell line 7 (ChiPSC7) (Cat. No. Y00270, not sold separay; sold as a part of Cat. No. Y00275)
Cellartis human iPS cell line 12 (ChiPSC12) (Cat. No. Y00280, not sold separay; sold as a part of Cat. No. Y00285)
Cellartis human iPS cell line 18 (ChiPSC18) (Cat. No. Y00300, not sold separay; sold as a part of Cat. No. Y00305)
Cellartis human iPS cell line 21 (ChiPSC21) (Cat. No. Y00310, not sold separay; sold as a part of Cat. No. Y00315)
Cellartis human iPS cell line 22 (ChiPSC22) (Cat. No. Y00320, not sold separay; sold as a part of Cat. No. Y00325)
B. Cellartis DEF-CS 100 Culture System
· Cellartis DEF-CS 100 Culture System (Cat. No. Y30020, not sold separay; sold as a part of Cat.Nos. Y00185, Y00225, Y00265, Y00275, Y00285, Y00305, Y00305, and Y00315. A larger 500ml version of this product is sold as Cat. No. Y00310.)
o DEF-CS Basal Medium (100 ml)
o DEF-CS COAT-1 (for 100 ml) (800 µl)
o DEF-CS GF-1 (for 100 ml) (300 µl)
o DEF-CS GF-2 (for 100 ml) (100 µl)
o DEF-CS GF-3 (for 100 ml) (40 µl)
另行準備材料:PBS+TrypLE 選擇酶+TC處理ps表面培養(yǎng)器皿
The following materials are required but not supplied:
· PBS Dulbecco's with Ca2+ & Mg2+ (D-PBS +/+)
· PBS Dulbecco's without Ca2+ or Mg2+ (D-PBS –/–)
· TrypLE Select Enzyme (1X), no phenol red
· Cell culture vessels, Tissue culture treated polystyrene surface
· General cell culture equipment used in cell culture laboratory
參考文獻:
1. de Peppo GM, et al. Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A.2010 Nov;16(11):3413-3426.
2. Both SK, et al. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med.2011 Mar;5(3):180-190.
3. de Peppo GM, et al. Free-form-fabricated commercially pure Ti and Ti6A14V Porous Scaffolds support the growth of human embryonic stem cell-derived mesodermal progenitors. ScientificWorldJournal. 2012;2012:646417.Epub 2012 Jan 4.
4. Ou Li, et al. Human embryonic stem cell-derived mesenchymal stroma cells(hES-MSCs) engraft in vivo and support hematopoiesis without suppression immune function: implications for off –the shelf ES-MSC therapies. PLOS ONE.2013; 8(1):e55319.
Cellartis 人iPS誘導多能干細胞訂購信息
不同貨號的區(qū)別:iPS細胞供體不同
品牌 | Code No. | 包裝量 | 價格 |
Cellartis | Y00185 | 1 Kit | 22718 元 |
Cellartis | Y00275 | 1 Kit | 22718 元 |
Cellartis | Y00285 | 1 kit | 22718 元 |
Cellartis | Y00315 | 1 Kit | 22718 元 |
Cellartis | Y00325 | 1 kit | 22718 元 |
Cellartis | Y00305 | 1 Kit | 22718 元 |
關(guān)聯(lián)產(chǎn)品
人iPS細胞*培養(yǎng)基
http://www.chem17.com/st321032/Product_29103798.html
華雅再生醫(yī)學旗艦公司:紅榮微再(上海)生物工程技術(shù)有限公司主營細胞治療和精準醫(yī)療等產(chǎn)品,2018年與TAKARA繼續(xù)合作,授權(quán)代理(上海)其旗下Cellartis干細胞研究制品和Rubicon單細胞文庫構(gòu)建試劑。Cellartis公司位于瑞典,擁有iPS細胞等干細胞分化為肝細胞及臟器細胞的分化誘導技術(shù)和ES細胞,ips細胞,分化細胞等干細胞相關(guān)產(chǎn)品。
手機1500 1904 520 紅榮微再-客服 經(jīng)銷商專員